We demonstrate that TSPAN32 is broadly downregulated in these leukemias and inversely correlates with cell cycle gene expression, supporting a model in which TSPAN32 acts as a quiescence-promoting factor whose silencing facilitates oncogenic proliferation. Here, TSPAN32 is linked to leukemia.